πŸ‡ΊπŸ‡Έ FDA
Patent

US 10004800

Antibody evolution immunogens

granted A61KA61K2039/57A61K39/12

Quick answer

US patent 10004800 (Antibody evolution immunogens) held by The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer
Grant date
Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/57, A61K39/12, A61K39/21, A61P